CLINICAL_TRIALS
trial_result
· 2025-12-22
Clinical Trial Update: Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell) [Phase 3]
Summary
Phase 3 trial of Sabin strain inactivated poliovirus vaccine (Vero cell) for poliomyelitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Minhai Biotechnology Co., Ltd | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED